Cargando…
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
There are over 15 disease-modifying drugs that have been approved over the last 20 years for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited treatment options available for progressive MS. The development of new drugs for the treatment of progressive MS remains ch...
Autores principales: | Kamma, Emily, Lasisi, Wendy, Libner, Cole, Ng, Huah Shin, Plemel, Jason R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830034/ https://www.ncbi.nlm.nih.gov/pubmed/35144628 http://dx.doi.org/10.1186/s12974-022-02408-y |
Ejemplares similares
-
The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models
por: Libner, Cole D., et al.
Publicado: (2020) -
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
por: Baaklini, Charbel S., et al.
Publicado: (2019) -
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
por: Perry, V. Hugh, et al.
Publicado: (2013) -
Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System
por: Chandramowlishwaran, Pavithra, et al.
Publicado: (2020) -
Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?
por: Fominykh, Vera, et al.
Publicado: (2018)